Diamedica Therapeutics Inc. · NASDAQ:DMAC
Trill AB reported a 15.02% stake in Diamedica Therapeutics Inc. (Schedule 13G/A)
Event Aug 14, 2025 · Filed Sep 4, 2025
Trill AB reported a 15.02% stake in Diamedica Therapeutics Inc., 7,764,465 shares, as a passive investor on Aug 14, 2025. Filed Sep 4, 2025 (Schedule 13G/A).
- Stake
- 15.02%
- Shares
- 7,764,465
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Trill AB | 15.02% | 7,764,465 |
| Jan Stahlberg | 15.02% | 7,764,465 |
Source
Related
- Diamedica Therapeutics Inc.
- Trill AB
- Diamedica Therapeutics Inc. shareholders
- Schedule 13G/A · Trill AB · Feb 6, 2026
- Schedule 13G/A · Trill AB · Jul 30, 2025
- Form 4 · Pauls Dietrich John · Aug 12, 2026
- Schedule 13G/A · John Fichthorn · Feb 17, 2026
- Schedule 13G/A · Cooperman Leon G · Feb 17, 2026
- Schedule 13G/A · Richard Jacinto II · Nov 7, 2025
- Schedule 13G/A · Cooperman Leon G · Oct 15, 2025